After-Market: $70.76 +0.01 (0.01 %) 7:10 PM ET
ETF Quote Details
|NAV (month end)||72.92|
|Premium (+)/Discount (-) (month end)||-0.52|
Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.
This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:
See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs
ETF Expense Ratio
|Dividend (Yield)||$1.19 (1.65%)|
This benchmark index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.
The Market Vectors Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index. The Index is a rules based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.